Baicalein and wogonin inhibit collagen deposition in SHR and WKY cardiac fibroblast cultures

BMB Reports

Volumn 43, Issue 4, 2010, Pages 297-303

  Kong, Ebenezer KC ^a,b   Huang, Yu ^a,c   Sanderson, John E ^a,b   Chan, Kar Bik ^b   Yu, Shan ^a,b   Yu, Cheuk Man ^a,b  

^a Li Ka Shing Institute of Health Sciences   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Baicalein; Cardiac fibroblast; Collagen; Fibrosis; Wogonin

Indexed keywords

RATTUS;

EID: 77953481127     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2010.43.4.297     Document Type: Article

References (39)

1. Yu, C. M., Tipoe, G. L., Lai, K. W. H. and Lau, C. P. (2001) Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction. J. Am. Coll. Cardiol. 38, 1207-1215.
2. Weber, K. T., Sun, Y., Guarda, E., Katwa, L. C., Ratajska, A., Cleutjens, J. P. and Zhou, G. (1995) Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory mechanisms. Eur. Heart J. 16(Suppl C), 24-28.
3. Weber, K. T. and Brilla, C. G. (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83, 1849-1865.
4. Weber, K. T., Janicki, J. S., Shroff, S. G., Pick, R., Chen, R. M. and Bashey, R. I. (1988) Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ. Res. 62, 757-765.
5. Matsubara, L. S., Matsubara, B. B., Okoshi, M. P., Franco,M. and Cicogna, A. C. (1997) Myocardial fibrosis rather than hypertrophy induces diastolic dysfunction in renovascular hypertensive rats. Can. J. Physiol. Pharmacol. 75, 1328-1334.
6. Brilla, C. G., Rupp, H., Funck, R. and Maisch, B. (1995) The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur. Heart J. 16, 107-109.
7. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ. Res. 82, 1338-1348
8. Wen, Y., Gu, J., Liu, Y., Wang, P. H., Sun, Y. and Nadler, J. L. (2001) Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth. Circ. Res. 88, 70-76.
9. Wen, Y., Nadler, J. L., Gonzales, N., Scott, S., Clauser, E. and Natarajan, R. (1996) Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase. Am. J. Physiol. 271, C1212-1220.
10. Robert, V., Besse, S., Sabri, A., Silvestre, J. S., Assayag, P., Nguyen, V. T., Swynghedauw, B. and Delcayre, C. (1997) Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab. Invest. 76, 729-738.
11. Fedak, P. W., Verma, S., Weisel, R. D. and Li, R. K.(2005) Cardiac remodeling and failure From molecules to man (Part II). Cardiovasc. Pathol. 14, 49-60.
12. Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jr., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., Jr. and Roccella, E. J. (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J. Am. Med. Assoc. 289, 2560-2572.
13. Brilla, C. G., Matsubara, L. and Weber, K. T. (1996) Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis. Hypertension 28, 269-275.
14. Brilla, C. G., Matsubara, L. S. and Weber, K. T. (1993) Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J. Mol. Cell. Cardiol. 25, 563-575.
15. Huang, Y., Tsang, S. Y., Yao, X. and Chen, Z. Y. (2005) Biological properties of baicalein in cardiovascular system. Curr. Drug Targets. Cardiovasc. Haematol. Disord. 5, 177-184.
16. Zhang, Z. P., Wang, L. J. and Yao, Q. H. (2007) Expression of Saccharomyces cerevisiae Hem1 recombined with Arabidopsis thaliana HemA1 promoter in transgenic tobacco. Acta. Bot. Boreal.-Occident. Sin. 27, 1929-1936. (in Chinese with English abstract)
17. Zhang, Z. P., Wang, L. J. and Yao, Q. H. (2008) Study on leaf photosynthesis and chlorophyll fluorescence of transgenic tobacco over-producing 5-aminolevulinic acid (ALA). Acta. Bot. Boreal.-Occident. Sin. 28, 1196-1202. (in Chinese with English abstract)
18. Shimizu, I., Ma, Y. R., Mizobuchi, Y., Liu, F., Miura, T., Nakai, Y., Yasuda, M., Shiba, M., Horie, T., Amagaya, S., Kawada, N., Hori, H. and Ito, S. (1999) Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29, 149-160.
19. Ono, M., Miyamura, M., Kyotani, S., Saibara, T., Ohnishi, S. and Nishioka, Y. (1999) Effects of Sho-saiko-to extract on liver fibrosis in relation to the changes in hydroxyproline and retinoid levels of the liver in rats. J. Pharm. Pharmacol. 51, 1079-1084.
20. Chen, K., Chen, J., Li, D., Zhang, X. and Mehta, J. L. (2004) Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension 44, 655-661.
21. Kim, S. and Iwao, H. (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol. Rev. 52, 11-34.
22. Horiuchi, M., Akishita, M. and Dzau. V. J. (1999) Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33, 613-621.
23. Wang, Z. Q., Moore, A. F., Ozono, R., Siragy, H. M. and Carey, R. M. (1998) Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension 32, 78-83.
24. Shivakumar, K., Dostal, D. E., Boheler, K., Baker, K. M. and Lakatta, E. G. (2003) Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. Am. J. Physiol. Heart Circ. Physiol. 284, H1454-1459.
25. Schorb, W., Conrad, K. M., Singer, H. A., Dostal, D. E. and Baker, K. M. (1995) Angiotensin II is a potent stimulator of MAP-kinase activity in neonatal rat cardiac fibroblasts. J. Mol. Cell. Cardiol. 27, 1151-1160.
26. Munshi, H. G., Wu, Y. I., Mukhopadhyay, S., Ottaviano, A. J., Sassano, A., Koblinski, J. E., Platanias, L. C. and Stack, M. S. (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J. Biol. Chem. 279, 39042-39050.
27. Levick, S. P., Loch, D. C., Taylor, S. M. and Janicki, J. S. (2007) Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J. Immunol. 178, 641-646.
28. Li, Y. Y., McTiernan, C. F. and Feldman, A. M. (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 46, 214-224.
29. Vellaichamy, E., Khurana, M. L., Fink, J. and Pandey, K. N. (2005) Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J. Biol. Chem. 280, 19230-19242.
30. Graham, H. K. and Trafford, A. W. (2007) Spatial disruption and enhanced degradation of collagen with the transition from compensated ventricular hypertrophy to symptomatic congestive heart failure. Am. J. Physiol. Heart Circ. Physiol. 292, H1364-1372.
31. Rouet-Benzineb, P., Gontero, B., Dreyfus, P. and Lafuma, C. (2000) Angiotensin II induces nuclear factor- kappa Bactivation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway. J. Mol. Cell. Cardiol. 32, 1767-1778.
32. Fullerton, M. J. and Funder, J. W. (1994) Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc. Res. 28, 1863-1867.
33. Morales, M. O., Price, R. L. and Goldsmith, E. C. (2005) Expression of discoidin domain receptor 2 (DDR2) in the developing heart. Microsc. Microanal. 11, 260-267.
34. Miki, T., Miura, T., Nishino, Y., Yano, T., Sakamoto, J., Nakamura, Y., Ichikawa, Y., Ikeda, Y., Kobayashi, H., Ura, N. and Shimamoto, K. (2004) Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin. Exp. Pharmacol. Physiol. 31, 873-882.
35. Li, Z., Tran, T. T., Ma, J. Y., O'Young, G., Kapoun, A. M., Chakravarty, S., Dugar, S., Schreiner, G. and Protter, A. A. (2004) p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J. Cardiovasc. Pharmacol. 44, 486-492.
36. Livak, K. J. and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
37. Puchtler, H., Meloan, S. N. and Waldrop, F. S. (1988) Are picro-dye reactions for collagens quantitative? Chemical and histochemical considerations. Histochemistry 88, 243-256.
38. Junquiera, L. C., Junqueira, L. C. and Brentani, R. R. (1979) A simple and sensitive method for the quantitative estimation of collagen. Anal. Biochem. 94, 96-99.
39. Yang, J., Zhang, S., Zhou, Q., Guo, H., Zhang, K., Zheng, R. and Xiao, C. (2007) PKHD1 Gene silencing may cause cell abnormal proliferation through modulation of intracellular calcium in autosomal recessive polycystic kidney disease. J. Biochem. Mol. Biol. 40, 467-474.